Apotheken | Arzt | Interaktionen | Medikamente | MiGeL | Services | Spital | Zulassungsi.
N04BD02 - RasagilineATC-DDD Version 2016. Source: WHO
N - Nervous System
N04 - Anti-Parkinson Drugs

This group comprises preparations used in the treatment of Parkinsons disease and related conditions, including drug-induced parkinsonism.

The DDDs are based on recommended doses for the long-term treatment of symptoms of Parkinsons disease.
No separate DDDs are established for oral depot formulations.

N04B - Dopaminergic Agents
N04BD - Monoamine Oxidase B Inhibitors
N04BD02 - Rasagiline
2023 ©ywesee GmbH
Einstellungen | Hilfe | FAQ | Anmeldung | Kontakt | Home